Reuters logo
BRIEF-Immune design announces G100’s receipt of orphan drug designation by EMA
October 19, 2017 / 8:13 PM / a month ago

BRIEF-Immune design announces G100’s receipt of orphan drug designation by EMA

Oct 19 (Reuters) - Immune Design Corp

* Immune design announces G100’S receipt of orphan drug designation by the EMA for the treatment of follicular non-Hodgkin’s lymphoma Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below